Articles from Digbi Health

New digital card platform offers a unified alternative to fragmented manufacturer programs, giving employers enhanced control over the Budget, Behavior, and Biology of obesity care

Actuarial claims analysis confirms up to 9X ROI across GLP-1, Metabolic, and GI Costs, demonstrating the power of gut microbiome and genetics-based biomarker care

The industry-leading, Precision Biology-based GLP-1 digital companion program Digbi Care (™) gets even better by incorporating continuous glucose monitor, additional gut microbiome, and genetic traits to personalize obesity care.

Digbi Health, a leader in Precision Biology and personalized healthcare, has been invited to present a landmark study at the Obesity Society Conference. The study demonstrates how the Digbi Health program successfully alters the gut microbiome to produce compounds that increase the body's natural production of endogenous GLP-1 (glucagon-like peptide-1). This breakthrough approach shows promise in reducing GLP-1 medication dosages, improving weight loss, improving drug adherence, and lowering treatment costs for employers, health plans, and consumers while enhancing long-term weight loss outcomes.

Digbi Health, a leader in Precision biology-based care for obesity, type 2 diabetes, and gastrointestinal health, is excited to announce its SEC-regulated raise. This initiative allows millions to invest in the company's mission to transform healthcare by expanding access to personalized, genetics-based, and gut microbiome-driven treatments.

Digbi Health expands its award-winning multi-condition telehealth platform with the introduction of a comprehensive solution that leverages genetic insights, gut microbiome analysis, and continuous glucose monitors (CGMs) to improve the effectiveness of GLP-1 drugs and guarantee successful medication tapering.

Digbi Health, a leader in Precision Biology for obesity and chronic disease management, today announced that a prominent public health insurance trust has chosen the company to manage the growing costs and effective utilization of GLP-1 weight-loss drugs for municipal and teachers union workers. This strategic partnership expands Digbi Health's employer offering, integrating its GLP-1 Obesity Management Solution across payers, pharmacy benefit managers (PBMs), providers, and employers.

Digbi Health, the leader in precision biology-based telehealth care for three of the top four healthcare costs - Obesity, T2D, and Digestive Health - announced today the launch of its latest innovation in obesity care, Digbi GLP-Fit™, a scientifically-backed approach to identify the best treatment path for an individual to prevent and treat obesity.